Practice-changing information you can apply to the next patient you see

This live educational meeting is intended for practicing clinicians of the multidisciplinary cancer care team including physicians, physician assistants, nurses and pharmacists. Physicians can earn up to 16.5 AMA PRA Category 1 Credit(s)™.

The program will cover the practical application of immunotherapy and precision medicine for the treatment of:

  • LUNG CANCER
  • SKIN CANCER
  • HEAD AND NECK CANCER
  • GENITOURINARY CANCER
  • GASTROINTESTINAL CANCER
  • WOMEN’S HEALTH

The focus is entirely on practice-changing information – offering the what, the why and the how – so that attendees leave this meeting with the confidence to use what was learned and apply it to the very next patient they see.

Faculty will offer brief, insightful presentations in engaging formats such as case presentations, panel discussions and question/answer sessions to ensure all information covered is data-driven and explained how to practically apply in practice. Interactive sessions include Controversies and Debates, Tumor Boards, Side Effects and What Will You Do On Monday.

Please join us in New York City for this insightful and engaging educational event!

Meet the Program Directors

Sanjiv S. Agarwala, MD
“Oncology is a rapidly changing and complicated field. Join us this spring to interact with the top experts in the field and to gain the perspective and pearls you need to make sense of new data and trends. You’ll leave with take home messages that you can apply in your practice and improve the outcomes of your patients.”
— Sanjiv S. Agarwala, MD | Program Co-Director
Edward S. Kim, MD, FACP
“This program is focused on the ‘practicing’ clinician – featuring useful, practice-changing information for the multidisciplinary team. Faculty will offer valuable interpretation of data so the newest treatments, diagnostics and biomarkers can be incorporated immediately into practice. Clinicians will also find the case-based discussions to be significantly meaningful, made possible by the smaller size of this meeting.”
— Edward S. Kim, MD, FACP | Program Co-Director
Joyce A. O’Shaughnessy
“CME programs like this one that synthesize and vet the most important, clinically relevant treatment and diagnostic information for practicing oncologists are essential – especially given how rapidly new data and treatment options are becoming available. It’s extremely valuable to discuss the controversial areas of management with faculty and colleagues to hear all sides of the data.”
— Joyce A. O’Shaughnessy, MD | Program Co-Director
This continuing medical education activity is provided by
Official Media Partner
 

We’ve made significant changes to the 2020 meeting!